Kendall Law Group, a national securities firm, is investigating ATS Medical, Inc. (NASDAQ: ATSI) for shareholders in connection with the proposed sale of the Company to Medtronic Inc. The firm’s investigation seeks to determine whether ATS and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are an ATS shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at skendall@kendalllawgroup.com.

On April 29, 2010, the companies announced that they had entered into an agreement for ATS to be acquired by Medtronics for $370 million. According to the agreement, ATS shareholders will receive $4.00 per share. The agreement includes a $13 million termination fee, making it unlikely that ATS will solicit other offers.

Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in dozens of merger and acquisition cases nationwide, including some of the largest transactions in the United States.

Ats Medical (MM) (NASDAQ:ATSI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Ats Medical (MM).
Ats Medical (MM) (NASDAQ:ATSI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Ats Medical (MM).